Table 1.
Demographics, comorbidities, and medical care received among COVID-19 patients, overall and according to disease outcome.
| Characteristics | All (N = 513) | Survived (N = 490) | Died (N = 23) |
|---|---|---|---|
| Age, median (range), years | 60 (19–94) | 59 (19–94) | 75 (31–93) |
| Male, no. (%) | 253 (49%) | 240 (49%) | 13 (57%) |
| Comorbidities, no (%) | |||
| Any | 256 (50%) | 236 (48%) | 20 (87%) |
| Diabetes | 58 (11%) | 51 (10%) | 7 (30%) |
| Hypercholesterolemia | 52 (10%) | 49 (10%) | 3 (13%) |
| Hypertension | 178 (35%) | 163 (33%) | 15 (65%) |
| Cardiovascular disease | 56 (11%) | 47 (10%) | 9 (39%) |
| Solid tumor | 15 (3%) | 14 (3%) | 1 (4%) |
| Hematological tumor | 10 (2%) | 7 (1%) | 3 (13%) |
| Medical care, no. (%) | |||
| Non-hospitalized | 118 (23%) | 118 (24%) | 0 (0%) |
| Hospitalized | 395 (77%) | 372 (76%) | 23 (100%) |
| ICU | 32 (6%) | 19 (4%) | 13 (57%) |
| Hospitalization, median (range), days | 8 (1–50) | 7 (1–50) | 12 (1–32) |
| Follow-up, median (range), days | 59 (1–129) | 63 (1–129) | 12 (1–62) |
ICU, intensive care unit.